Voices
Naveen Pemmaraju: New Research on NPM1 Mutations in AML
Naveen Pemmaraju/ youtube.com

Naveen Pemmaraju: New Research on NPM1 Mutations in AML

Naveen Pemmaraju, Professor in the Department of Leukemia at UT MD Anderson Cancer Center, shared on X:

”Our group’s new paper Clinical outcomes associated with NPM1 mutations in newly diagnosed AML – Farhat – 2026 – ACS Journal Cancer.”

Title: Clinical outcomes associated with NPM1mutations in newly diagnosed acute myeloid leukemia

Authors: Aziz Farhat, Georgina El Hajjar, Hagop Kantarjian, Koji Sasaki, Nicholas J. Short, Branko Cuglievan, Sanam Loghavi, Keyur Patel, Alex Bataller, Wei Ying Jen, Musa Yilmaz, Guillermo Montalban-Bravo, Danielle Hammond, Naveen Pemmaraju, Naval Daver, Farhad Ravandi, Elias Jabbour, Tapan Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Courtney D. DiNardo, Ghayas C. Issa

Read the full article.

Other articles about AML on OncoDaily.

Alex Bataller Aziz Farhat Branko Cuglievan cancer Courtney D. DiNardo Danielle Hammond Elias Jabbour Farhad Ravandi Gautam Borthakur Georgina El Hajjar Ghayas C. Issa Guillermo Garcia-Manero Guillermo Montalban-Bravo Hagop Kantarjian Keyur Patel Koji Sasaki Musa Yilmaz Naval Daver Naveen Pemmaraju Nicholas J. Short OncoDaily Oncology Sanam Loghavi Tapan Kadia Wei Ying Jen